Therasense Stock Today
Performance0 of 100
| Odds Of DistressOver 88
|
Therasense has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of June 2023 and ending today, the 11th of December 2024. Click here to learn more.
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. The company has 6.15 B outstanding shares of which 199.92 K shares are at this time shorted by private and institutional investors with about 2.6 trading days to cover. More on Therasense
Therasense cannot be verified against its exchange. Apparently, Therasense is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshTherasense Pink Sheet Highlights
| Old Name | Thermocompact SA |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Therasense [THER] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Therasense's market, we take the total number of its shares issued and multiply it by Therasense's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Therasense conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 6.15 B outstanding shares of which 199.92 K shares are at this time shorted by private and institutional investors with about 2.6 trading days to cover.
Therasense currently holds about 127.82 K in cash with (5.54 M) of positive cash flow from operations.
Check Therasense Probability Of Bankruptcy
Therasense Stock Against Markets
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Therasense without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.